GLP-1 class safety monitoring should include awareness of these important risks: Pancreatitis : Patients should promptly report severe abdominal pain, with or without vomiting Gallbladder disease : Report symptoms of biliary colic or cholecystitis Acute kidney injury : Maintain adequate hydration, especially if experiencing nausea/vomiting Hypoglycemia : Increased risk when used with insulin or sulfonylureas Suicidal ideation : For patients using Wegovy or Zepbound, monitor for mood changes Patients should be counseled to report any neck swelling, difficulty swallowing, persistent hoarseness, or palpable thyroid nodules, as these warrant evaluation regardless of GLP-1 use
Generic semaglutide (Dr
Every milestone is acknowledged, which creates positive momentum and reinforces commitment
Then check out our GLP-1 plan and give your body something itll actually thank you for!
That happens sometimes with GLP-1s, since there are versions of the drug, like Ozempic, approved for type 2 diabetes but not obesity management
Sajan can help create the right weight loss program with Semaglutide for you.